Quick Answer
Tropical parasitology is one of the highest-yield NEET PG microbiology clusters — and it is India-heavy because India carries the world's largest kala-azar, lymphatic filariasis and P. vivax burden.
- Malaria — P. falciparum (severe, cerebral, blackwater), P. vivax (hypnozoites — primaquine 14 days after G6PD), P. ovale, P. malariae (quartan), P. knowlesi (zoonotic macaque).
- First-line uncomplicated falciparum in India — ACT-SP everywhere except north-east (ACT-AL). Severe — IV artesunate.
- Kala-azar (visceral leishmaniasis) — Bihar–Jharkhand–UP–WB endemic; splenomegaly + pancytopenia + fever; rK39 rapid test; single 10 mg/kg LAmB under NKAEP.
- Lymphatic filariasis — W. bancrofti + B. malayi; nocturnal microfilaraemia; India MDA now uses IDA triple therapy (ivermectin + DEC + albendazole).
- Amoebiasis — flask-shaped colonic ulcer + right-lobe liver abscess (anchovy-sauce pus); metronidazole PLUS a luminal agent (paromomycin / diloxanide).
- Giardiasis — malabsorption + greasy stool; kite-shaped trophozoite; metronidazole / tinidazole / nitazoxanide.
Parasitology in NEET PG is dominated by six vector-borne or faeco-orally transmitted infections that map directly to India's public-health programmes — malaria, kala-azar, filariasis, amoebiasis, giardiasis and toxoplasmosis. Examiners love these because the same stems recur at INI-CET, AIIMS and JIPMER, and because India's NVBDCP and NKAEP regimens have shifted meaningfully in the last five years.
This NEETPGAI deep dive covers Plasmodium species biology, the ACT ladder, kala-azar single-dose LAmB, filariasis triple therapy and amoebic-versus-Giardia stool microscopy — the exam patterns you can bank on. Pair it with the antibiotic pharmacology classification guide for the broader antimicrobial framework.
Malaria — species, life cycle and diagnosis
Five Plasmodium species infect humans. P. falciparum drives severe disease and almost all malaria deaths; P. vivax is the commonest species in India and carries dormant liver hypnozoites; P. malariae causes true quartan fever every 72 hours; P. ovale is rare (West African) and also has hypnozoites; P. knowlesi is a zoonotic macaque parasite emerging in South-East Asia with a 24-hour cycle.
Life cycle (rapid version)
Female Anopheles bite → sporozoites enter blood → hepatic schizogony (dormant hypnozoites for vivax and ovale) → merozoites released → erythrocytic schizogony (the fever cycle) → some develop into male and female gametocytes → next mosquito bite completes transmission with sporogony in the mosquito gut.
Clinical spectrum
| Feature | Uncomplicated | Severe / complicated (P. falciparum) |
|---|
| Fever | Paroxysmal — tertian (48h) for vivax/ovale/falciparum; quartan (72h) for malariae | Continuous, high-grade |
| Splenomegaly | Common | Common; risk of splenic rupture in vivax |
| CNS | Headache, myalgia | Cerebral malaria — impaired consciousness, seizures |
| Renal | — | Acute kidney injury; blackwater fever (massive haemolysis + haemoglobinuria) |
| Lung | — | ARDS |
| Metabolic | — | Hypoglycaemia (worse with quinine), lactic acidosis |
| Hematology | Anaemia | Severe anaemia (Hb less than 7 g/dL), DIC, thrombocytopenia |
Diagnosis
- Thick + thin peripheral blood smear with Giemsa stain — the gold standard. Thick film for parasite detection at low parasitaemia, thin film for species identification.
- Rapid diagnostic tests (RDTs) — HRP-2 (histidine-rich protein 2) detects P. falciparum; pLDH or aldolase for non-falciparum. India's NVBDCP uses bivalent kits (HRP-2 + pan-pLDH) to detect and distinguish falciparum from vivax at the field level.
- PCR — highest sensitivity, used for mixed infections and species confirmation.
- Serology — retrospective epidemiology only, not useful for acute diagnosis.
Malaria treatment — the ACT ladder
Uncomplicated P. falciparum (India NVBDCP 2024)
- ACT-SP (artesunate + sulfadoxine-pyrimethamine) — 3-day regimen; used in all states EXCEPT the north-east.
- ACT-AL (artemether + lumefantrine) — north-east states where SP resistance is documented.
- Single-dose primaquine 0.75 mg/kg on day 2 — gametocytocide to interrupt transmission (not a hypnozoiticide dose).
- Other options — artesunate + amodiaquine, dihydroartemisinin + piperaquine.
Severe / complicated falciparum
- IV artesunate 2.4 mg/kg at 0, 12, 24 hours then daily — replaces quinine as first-line worldwide since the AQUAMAT and SEAQUAMAT trials showed lower mortality.
- Continue at least 24 hours parenterally, then complete with a full 3-day oral ACT course.
- Monitor for post-artesunate delayed haemolysis (7–21 days after treatment).
P. vivax and P. ovale — eradicate the hypnozoites
- Chloroquine 25 mg/kg over 3 days for the erythrocytic phase (still effective in most of India; chloroquine-resistant vivax is emerging).
- Primaquine 0.25 mg/kg/day for 14 days as radical cure — required to clear liver hypnozoites and prevent relapse. Check G6PD status first — primaquine causes severe oxidative haemolysis in G6PD deficiency. Alternative: tafenoquine single dose (needs G6PD normal by quantitative assay).
Chemoprophylaxis
For travellers and non-immune Indians moving to hyper-endemic zones — doxycycline 100 mg/day, mefloquine weekly, or atovaquone-proguanil daily.
Leishmaniasis — kala-azar, PKDL and cutaneous forms
Three clinical syndromes caused by Leishmania species and transmitted by female Phlebotomus sandflies.
| Form | Species | Key clinical clue |
|---|
| Visceral (kala-azar) | L. donovani (India), L. infantum | Fever + massive splenomegaly + hepatomegaly + pancytopenia + hyperpigmentation ("kala azar" = black fever) |
| PKDL | L. donovani (post-treatment sequela) | Hypopigmented macules → nodules on face; infection reservoir |
| Cutaneous | L. tropica, L. major | Oriental sore — chronic non-healing ulcer at bite site |
| Mucocutaneous | L. braziliensis (New World) | Espundia — destructive nasopharyngeal ulceration |
India context — the NKAEP elimination story
India's kala-azar burden concentrates in Bihar (Muzaffarpur), Jharkhand, Uttar Pradesh and West Bengal. The National Kala-Azar Elimination Programme (NKAEP) uses single-dose 10 mg/kg IV liposomal amphotericin B as first-line therapy and achieved the elimination threshold (fewer than 1 case per 10,000 population at block level) in 2023. Alternatives — miltefosine oral 28 days (teratogenic — contraception mandatory), paromomycin IM.
Diagnosis
- Splenic aspirate — LD (Leishman-Donovan) bodies; highest sensitivity but risky.
- Bone marrow aspirate — safer alternative.
- rK39 rapid immunochromatographic test — 95%+ sensitivity for L. donovani; the workhorse of field diagnosis under NKAEP.
- PCR — reference-lab confirmation.
- PKDL — clinical + slit-skin smear + PCR.
Filariasis — lymphatic and beyond
Lymphatic filariasis in India is caused by Wuchereria bancrofti (95%) transmitted by Culex quinquefasciatus, and Brugia malayi (5%) transmitted by Mansonia mosquitoes. Adult worms live in lymphatics; microfilariae circulate in blood.
Clinical spectrum
- Acute — recurrent adenolymphangitis, fever, tender lymphadenopathy.
- Chronic — lymphoedema → elephantiasis (leg, scrotum), hydrocele (bancroftian only), chyluria (thoracic-duct obstruction).
- Tropical pulmonary eosinophilia (TPE) — hyperreactive form with paroxysmal nocturnal cough, wheeze, very high IgE, blood eosinophilia; responds dramatically to DEC.
Diagnosis
- Thick blood smear at night (10 pm – 2 am) — nocturnal periodicity of microfilariae.
- Filarial antigen ICT (immunochromatographic test) for W. bancrofti — day-time collection; used in national surveillance.
- Ultrasound "filarial dance sign" — writhing adult worm inside dilated scrotal lymphatic vessel; pathognomonic.
- Brugia has no antigen test — antibody assays used.
Treatment and MDA
- Individual case — DEC 6 mg/kg/day × 12 days plus albendazole 400 mg, plus doxycycline 200 mg/day × 6 weeks (targets Wolbachia endosymbiont → adulticidal).
- India NPELF Mass Drug Administration — moved from two-drug (DEC + albendazole) to the WHO-endorsed IDA triple therapy (ivermectin + DEC + albendazole) once annually in endemic districts. Ivermectin is contraindicated where loiasis co-exists — not an issue in India.
- Morbidity management — hygiene, elevation, compression, hydrocele surgery.
Amoebiasis
Caused by Entamoeba histolytica, transmitted faeco-orally by contaminated water. Two forms: cyst (infective) and trophozoite (invasive). Only trophozoites with ingested red cells confirm the invasive species — E. dispar and E. moshkovskii are morphologically identical but non-pathogenic.
Intestinal amoebiasis
- Flask-shaped ulcer on colonic mucosa — narrow neck, broad base — pathognomonic on histology.
- Bloody, mucoid diarrhoea (amoebic dysentery) with tenesmus; often afebrile — distinguishes from bacillary dysentery.
- Fulminant amoebic colitis and perforation in malnourished, pregnant, steroid-treated patients.
- Complication — amoeboma (granulomatous mass mimicking colon cancer).
Extra-intestinal amoebiasis
- Amoebic liver abscess — right lobe (85%), single, subdiaphragmatic; RUQ pain + tender hepatomegaly + fever + weight loss.
- Aspirate — anchovy-sauce pus (necrotic hepatocytes + blood), typically sterile on culture and free of trophozoites (they hug the abscess wall).
- Rupture into pleura, pericardium or peritoneum is the feared complication.
Diagnosis and treatment
- Stool microscopy — cysts (in carriers) or trophozoites with ingested RBCs (invasive).
- Stool antigen ELISA / PCR — species-specific; separates E. histolytica from E. dispar.
- Serology — high sensitivity for liver abscess (positive in 90%+ within 7 days).
- Treatment — invasive disease: metronidazole 750 mg TDS or tinidazole 2 g OD × 5–10 days, PLUS a luminal agent (paromomycin 25–35 mg/kg/day × 7 days or diloxanide furoate 500 mg TDS × 10 days) to eradicate the cyst-carrier state and prevent relapse.
- Asymptomatic cyst passer — luminal agent alone.
Giardiasis
Giardia lamblia (G. intestinalis / G. duodenalis) — a flagellate protozoan causing small-bowel disease. Transmitted by contaminated water (classic backpacker / mountaineer story), day-care centres and men who have sex with men.
- Kite-shaped or pear-shaped trophozoite with two nuclei and four pairs of flagella — one of the most recognisable stool findings in medicine.
- Oval cyst with four nuclei — the infective form.
- Attaches to duodenal mucosa via ventral sucking disc → villous blunting → malabsorption, steatorrhoea, greasy foul-smelling stool, flatulence, weight loss. Notably no invasion — no bloody diarrhoea.
- Diagnosis — stool microscopy (multiple samples due to intermittent shedding), stool antigen ELISA, duodenal aspirate ("string test" is historical).
- Treatment — metronidazole 250 mg TDS × 5–7 days or tinidazole 2 g single dose or nitazoxanide 500 mg BD × 3 days. Nitazoxanide preferred in children.
NEET PG MCQ traps
- P. vivax hypnozoites — need primaquine 14 days for radical cure; check G6PD first.
- P. knowlesi — zoonotic macaque parasite, 24-hour cycle; morphology mimics P. malariae; potentially severe.
- Cerebral malaria — always P. falciparum; treat with IV artesunate, not quinine.
- Blackwater fever — massive intravascular haemolysis, haemoglobinuria; classic in P. falciparum.
- Post-artesunate delayed haemolysis — 7–21 days later; check Hb at day 14.
- India ACT policy — ACT-SP everywhere except north-east (ACT-AL).
- rK39 — the rapid test for visceral leishmaniasis.
- Kala-azar single-dose LAmB — 10 mg/kg IV; NKAEP first-line.
- PKDL — treated with miltefosine 12 weeks; acts as human reservoir for onward transmission.
- Wuchereria vs Brugia vector — Culex vs Mansonia.
- Filarial dance sign — adult W. bancrofti on scrotal USG.
- India MDA for filariasis — now IDA triple therapy (ivermectin + DEC + albendazole).
- Doxycycline in filariasis — targets Wolbachia → adulticidal.
- Amoebic liver abscess — right lobe, anchovy-sauce pus, sterile aspirate, serology 90%+ positive.
- Flask-shaped ulcer — E. histolytica; kite-shaped trophozoite — Giardia.
- Luminal agent after metronidazole — paromomycin or diloxanide for E. histolytica; missed = relapse.
- Giardia — no dysentery, only malabsorption; nitazoxanide in children.
- Toxoplasma in pregnancy — spiramycin before 18 weeks, pyrimethamine + sulfadiazine + folinic acid after.
- Chagas disease — Trypanosoma cruzi; not endemic in India but tested — cardiomyopathy + megacolon.
- Trichomonas vaginalis — motile pear-shaped flagellate; strawberry cervix; treat partners with metronidazole.
India public-health context
- NVBDCP (National Vector Borne Disease Control Programme) — umbrella programme covering malaria, filariasis, kala-azar, dengue, chikungunya and Japanese encephalitis. Merged into the National Health Mission.
- NKAEP (National Kala-Azar Elimination Programme) — targeted elimination as a public-health problem in Bihar, Jharkhand, UP and WB. India crossed the threshold in 2023.
- NPELF (National Programme for Elimination of Lymphatic Filariasis) — annual MDA in endemic districts; IDA triple therapy rolled out from 2019 onwards.
- Malaria elimination target — India National Framework for Malaria Elimination aims for zero indigenous cases by 2027 and elimination certification by 2030.
- G6PD screening — mandated before primaquine (14-day) and tafenoquine under revised NVBDCP guidance.
- Rapid diagnostic tests — bivalent RDT (HRP-2 + pan-pLDH) rolled out to sub-centre level; every fever in an endemic district is tested before ACT.
- Anganwadi and ASHA workers — deliver DEC/albendazole in filariasis MDA rounds and complete DOTS-style adherence monitoring for kala-azar miltefosine courses.
Frequently asked questions
What is the current first-line treatment for uncomplicated Plasmodium falciparum malaria in India?
India's National Vector Borne Disease Control Programme (NVBDCP) recommends artemisinin-based combination therapy (ACT). For uncomplicated P. falciparum, ACT-SP (artesunate plus sulfadoxine-pyrimethamine) is used in all states except the north-east, where ACT-AL (artemether plus lumefantrine) is preferred due to documented SP resistance. A single dose of primaquine 0.75 mg per kg on day 2 is added as a gametocytocide to interrupt transmission. Severe falciparum needs IV artesunate for at least 24 hours, followed by a full oral ACT course. For P. vivax, chloroquine for 3 days plus primaquine 0.25 mg per kg per day for 14 days is standard to eradicate liver hypnozoites — G6PD status must be checked before primaquine to avoid haemolysis.
What is the single-dose kala-azar regimen under India's elimination programme?
The National Kala-Azar Elimination Programme (NKAEP) uses a single 10 mg per kg intravenous infusion of liposomal amphotericin B as the first-line regimen for visceral leishmaniasis in adults and children over 2 years. Miltefosine is a 28-day oral alternative but is teratogenic and requires contraception, and paromomycin injections are used as a combination partner in some sites. India, Bangladesh and Nepal committed to eliminate VL as a public-health problem (fewer than 1 case per 10,000 at block level), and India crossed that threshold in 2023. Post kala-azar dermal leishmaniasis (PKDL) is treated with 12 weeks of miltefosine because it acts as an infection reservoir.
What is the mass drug administration regimen for lymphatic filariasis in India?
India's National Programme for Elimination of Lymphatic Filariasis (NPELF) has moved from the two-drug regimen (DEC plus albendazole) to the three-drug WHO-endorsed triple therapy IDA — ivermectin plus DEC plus albendazole — administered annually in endemic districts. IDA achieves higher microfilaraemia clearance in a single round. DEC alone can precipitate Mazzotti-like reactions in loiasis and onchocerciasis co-endemic areas, but neither is prevalent in India. Doxycycline for 6 weeks targets the Wolbachia endosymbiont and sterilises adult worms — useful in individual case management but impractical for MDA.
How do you distinguish Entamoeba histolytica from Giardia lamblia clinically and on stool exam?
Entamoeba histolytica causes bloody, mucoid dysentery with tenesmus, plus extra-intestinal disease such as amoebic liver abscess (typically right lobe, anchovy-sauce pus). Stool microscopy shows haematophagous trophozoites — the presence of ingested red cells is pathognomonic for the invasive species. Giardia lamblia causes non-bloody, foul-smelling, greasy diarrhoea with malabsorption and gas — no invasion, no dysentery. Stool shows kite-shaped trophozoites with two nuclei or oval cysts with four nuclei. Both are treated with metronidazole or tinidazole, but E. histolytica additionally needs a luminal agent (paromomycin or diloxanide furoate) to eradicate cyst carriage and prevent relapse.
Which parasitic infections come up most often in NEET PG single-best-answer stems?
The NEET PG parasitology paper reliably tests: (1) cerebral malaria and its ACT ladder; (2) hypnozoite eradication with primaquine and the G6PD check; (3) kala-azar diagnosis by rK39 rapid test and single-dose LAmB; (4) filariasis nocturnal periodicity and the ultrasound filarial dance sign; (5) amoebic liver abscess presentation with right-lobe involvement and anchovy-sauce aspirate; (6) Giardia stool morphology and malabsorption; (7) Toxoplasma seroconversion in pregnancy and the spiramycin versus pyrimethamine-sulfadiazine split; (8) Wuchereria bancrofti vs Brugia malayi vector differences (Culex vs Mansonia). Master these eight and you have covered roughly 80 percent of parasitology single-best-answer marks.
This content is for educational purposes for NEET PG exam preparation. It is not a substitute for professional medical advice, diagnosis, or treatment. Clinical information has been reviewed by qualified medical professionals.
Written by: NEETPGAI Editorial Team
Reviewed by: Pending SME Review
Last reviewed: July 2026
